Name: Larimar Therapeutics, Inc. (LRMR) Balance Sheet
Creator: FinSpry

Larimar Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Larimar Therapeutics, Inc. (LRMR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	33.22	86.79	118.43	70.10	92.64
Short-Term Investments	150.24	60.04	91.60	0.00	24.49
Cash & Short-Term Investments	183.45	86.79	118.43	70.10	92.64
Accounts Receivable	1.05	0.33	0.00	0.21	0.03
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	10.80	3.05	2.31	0.28	5.28
Total Current Assets	195.30	90.18	120.74	72.20	97.95
Non-Current Assets
Property, Plant & Equipment (Net)	3.72	3.76	3.69	4.46	4.98
Other Non-Current Assets	1.20	2.00	1.98	2.01	1.76
Total Non-Current Assets	4.92	5.76	5.67	6.46	6.73
Total Assets	200.23	95.94	126.41	78.67	104.69
Current Liabilities
Accounts Payable	2.42	8.67	10.09	8.25	8.48
Short-Term Debt	1.06	0.00	0.00	0.00	0.00
Accrued Liabilities	20.87	7.39	8.41	6.59	5.84
Other Current Liabilities	20.87	2.37	2.05	1.10	1.35
Total Current Liabilities	24.36	9.51	10.71	8.85	8.99
Non-Current Liabilities
Long-Term Debt	4.06	4.71	4.80	5.41	6.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	4.06	4.71	4.80	5.41	6.00
Total Liabilities	28.41	14.22	15.50	14.25	14.99
Stockholders' Equity
Common Stock	0.06	0.04	0.04	0.02	0.02
Retained Earnings	-269.16	-188.52	-151.64	-116.25	-65.61
Accumulated Other Comprehensive Income	0.15	0.08	-0.03	0.00	0.00
Additional Paid-in Capital	440.76	270.15	262.50	180.65	155.29
Shares Outstanding	63.82	43.91	43.27	17.71	0.00
Total Stockholders' Equity	171.81	81.67	110.90	64.41	89.69
Total Liabilities & Equity	200.23	95.94	126.41	78.67	104.69